News

November 6, 2025

Cardiosense Presents New Analysis of the SEISMIC-HF I Study Validating its AI Algorithm for Noninvasive PCWP Assessment at the American Heart Association’s 2025 Scientific Sessions

October 28, 2025

Cardiosense Presents New Clinical Analysis of SEISMIC-HF I Data on AI-Enabled Volume Assessment in Heart Failure at the Transcatheter Cardiovascular Therapeutics (TCT) 2025 Scientific Symposium

September 18, 2025

Cardiosense Appoints Eric Meizlish as CEO to Advance AI-Enabled Cardiac Care

August 12, 2025

Cardiosense Appoints Medtech Executive John Martin, MD as EVP and Chief Medical Officer

July 30, 2025

Cardiosense Receives FDA 510(k) Clearance for the CardioTagTM Device, Paving the Way for Advanced Cardiac Function Monitoring

June 25, 2025

Cardiosense Announces Publication of SEISMIC-HF I Study Results in the Journal of the American College of Cardiology: Heart Failure

May 28, 2025

Cardiosense Launches Nationwide SEISMIC-HF II Study to Validate Its AI Algorithm for Non-Invasive Heart Failure Management

May 22, 2025

Cardiosense Noninvasively Measures Heart Failure’s Key Warning Signal

November 20, 2024

Results from Cardiosense’s SEISMIC-HF I Study of a Machine Learning Model to Non-Invasively Assess Cardiac Filling Pressure Presented as Late-Breaking Science at American Heart Association’s 2024 Scientific Sessions

October 29, 2024

Cardiosense Presents Interim Clinical Study Data for Machine Learning Algorithm to Aid in Heart Failure Management at the Transcatheter Cardiovascular Therapeutics (TCT) 2024 Scientific Symposium

May 14, 2024

Cardiosense CardioTag Named “Best IoT Healthcare Wearable Device” in 8th Annual MedTech Breakthrough Awards Program

October 3, 2023

Cardiosense Begins Enrollment in Nationwide Heart Failure Study

December 14, 2022

Cardiosense lands $15M for AI to predict worsening heart disease from wearables

December 8, 2022

Cardiosense, Inc., Completes $15.1 Million Series A Financing to Advance AI Platform for Heart Disease

April 13, 2022

Dr. Omer Inan shares insight on academia and entrepreneurship – for example, how do they interact…and can a person pursue both?

February 15, 2022

Cardiosense receives FDA Breakthrough Device designation for algorithm to identify patients at risk of decompensated heart failure

December 8, 2020